BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 27221200)

  • 1. Reduced SOD2 expression is associated with mortality of hepatocellular carcinoma patients in a mutant p53-dependent manner.
    Wang R; Yin C; Li XX; Yang XZ; Yang Y; Zhang MY; Wang HY; Zheng XF
    Aging (Albany NY); 2016 Jun; 8(6):1184-200. PubMed ID: 27221200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pterostilbene inhibits hepatocellular carcinoma through p53/SOD2/ROS-mediated mitochondrial apoptosis.
    Guo L; Tan K; Wang H; Zhang X
    Oncol Rep; 2016 Dec; 36(6):3233-3240. PubMed ID: 27748853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53-p66(shc)/miR-21-Sod2 signaling is critical for the inhibitory effect of betulinic acid on hepatocellular carcinoma.
    Yang J; Qiu B; Li X; Zhang H; Liu W
    Toxicol Lett; 2015 Nov; 238(3):1-10. PubMed ID: 26222667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloperoxidase and superoxide dismutase 2 polymorphisms comodulate the risk of hepatocellular carcinoma and death in alcoholic cirrhosis.
    Nahon P; Sutton A; Rufat P; Ziol M; Akouche H; Laguillier C; Charnaux N; Ganne-Carrié N; Grando-Lemaire V; N'Kontchou G; Trinchet JC; Gattegno L; Pessayre D; Beaugrand M
    Hepatology; 2009 Nov; 50(5):1484-93. PubMed ID: 19731237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
    Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
    BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of p53 overexpression after hepatic resection of hepatocellular carcinoma.
    Sung CO; Yoo BC; Koh KC; Cho JW; Park CK
    Korean J Gastroenterol; 2005 Jun; 45(6):425-30. PubMed ID: 15973077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SIRT1 regulates oncogenesis via a mutant p53-dependent pathway in hepatocellular carcinoma.
    Zhang ZY; Hong D; Nam SH; Kim JM; Paik YH; Joh JW; Kwon CH; Park JB; Choi GS; Jang KY; Park CK; Kim SJ
    J Hepatol; 2015 Jan; 62(1):121-30. PubMed ID: 25131770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-mobility group protein box1 expression correlates with peritumoral macrophage infiltration and unfavorable prognosis in patients with hepatocellular carcinoma and cirrhosis.
    Zhang QB; Jia QA; Wang H; Hu CX; Sun D; Jiang RD; Zhang ZL
    BMC Cancer; 2016 Nov; 16(1):880. PubMed ID: 27836008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
    Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
    Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S100P expression is a novel prognostic factor in hepatocellular carcinoma and predicts survival in patients with high tumor stage or early recurrent tumors.
    Yuan RH; Chang KT; Chen YL; Hsu HC; Lee PH; Lai PL; Jeng YM
    PLoS One; 2013; 8(6):e65501. PubMed ID: 23785431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein expression of p53, p21WAF1, and Rb as prognostic indicators in patients with surgically treated hepatocellular carcinoma.
    Naka T; Toyota N; Kaneko T; Kaibara N
    Anticancer Res; 1998; 18(1B):555-64. PubMed ID: 9568177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma.
    Hu TH; Huang CC; Lin PR; Chang HW; Ger LP; Lin YW; Changchien CS; Lee CM; Tai MH
    Cancer; 2003 Apr; 97(8):1929-40. PubMed ID: 12673720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-suppressor effect of interferon regulatory factor-1 in human hepatocellular carcinoma.
    Moriyama Y; Nishiguchi S; Tamori A; Koh N; Yano Y; Kubo S; Hirohashi K; Otani S
    Clin Cancer Res; 2001 May; 7(5):1293-8. PubMed ID: 11350897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NKD1 correlates with a poor prognosis and inhibits cell proliferation by inducing p53 expression in hepatocellular carcinoma.
    Zhang S; Li J; Wang X
    Tumour Biol; 2016 Oct; 37(10):14059-14067. PubMed ID: 27507614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.
    Peng SY; Chen WJ; Lai PL; Jeng YM; Sheu JC; Hsu HC
    Int J Cancer; 2004 Oct; 112(1):44-50. PubMed ID: 15305374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCR2-CXCL1 axis is correlated with neutrophil infiltration and predicts a poor prognosis in hepatocellular carcinoma.
    Li L; Xu L; Yan J; Zhen ZJ; Ji Y; Liu CQ; Lau WY; Zheng L; Xu J
    J Exp Clin Cancer Res; 2015 Oct; 34():129. PubMed ID: 26503598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EIF4EBP1 overexpression is associated with poor survival and disease progression in patients with hepatocellular carcinoma.
    Cha YL; Li PD; Yuan LJ; Zhang MY; Zhang YJ; Rao HL; Zhang HZ; Zheng XF; Wang HY
    PLoS One; 2015; 10(2):e0117493. PubMed ID: 25658620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RAMP3 is a prognostic indicator of liver cancer and might reduce the adverse effect of TP53 mutation on survival.
    Fang A; Zhou S; Su X; Liu C; Chen X; Wan Y; Lei X; Xie L; Jia Y; Wang W; Yang L; Song X; Yao Y
    Future Oncol; 2018 Oct; 14(25):2615-2625. PubMed ID: 29882679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of phosphatase and tensin homology deleted on chromosome ten(PTEN) and p53 protein and their significance in human hepatocellular carcinomas].
    Cheng LM; Wang SY; Lin JS
    Ai Zheng; 2003 Jan; 22(1):42-5. PubMed ID: 12561434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and prognostic significance of vascular endothelial growth factor receptor 1 in hepatocellular carcinoma.
    Li T; Zhu Y; Qin CY; Yang Z; Fang A; Xu S; Ren W
    J Clin Pathol; 2012 Sep; 65(9):808-14. PubMed ID: 22734007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.